Dr. Erba on Treating Chronic Phase CML with Second-Generation TKIs Targeted Oncology 1:53 11 years ago 103 Далее Скачать
Dr. Erba on the Diagnosis and Testing of Patients with CML OncLive 2:50 11 years ago 151 Далее Скачать
Second-Generation Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia OncLive 5:34 10 years ago 1 009 Далее Скачать
Benefits of second generation TKIs for CML in the frontline VJHemOnc – Video Journal of Hematology & HemOnc 1:46 6 years ago 73 Далее Скачать
Second-generation tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 3:12 9 years ago 653 Далее Скачать
Asciminib plus traditonal TKIs for chronic phase CML VJHemOnc – Video Journal of Hematology & HemOnc 3:08 6 years ago 636 Далее Скачать
Dr. Erba Discusses the Failure to Achieve a BCR-ABL Transcript Level Below 10% After Imatinib in CML OncLive 1:13 10 years ago 839 Далее Скачать
Dr. Erba on BCR-ABL Ratios in Patients with CML Targeted Oncology 1:59 10 years ago 2 652 Далее Скачать
Adverse Events of Second-Generation TKIs Used in Treating CML Targeted Oncology 5:57 5 years ago 38 Далее Скачать
Dr. Pamela Crilley on Imatinib and Second Generation TKIs Targeted Oncology 1:43 12 years ago 421 Далее Скачать
Dr. Harry Erba Discusses Molecular Monitoring for Chronic Myeloid Leukemia OncLive 1:15 12 years ago 271 Далее Скачать
The current standard of care in CML and insights into the use of first- and second-generation TKIs VJHemOnc – Video Journal of Hematology & HemOnc 3:20 2 years ago 47 Далее Скачать
Asciminib versus other TKIs in the frontline treatment of CML: the ASC4FIRST study VJHemOnc – Video Journal of Hematology & HemOnc 1:46 6 months ago 406 Далее Скачать
Chronic Myeloid Leukemia: Approaches to Optimizing Care in the Era of TKIs HMP Education 20:24 4 years ago 4 073 Далее Скачать
